News | August 18, 2025
European Commission grants approval of Ogsiveo
OGSIVEO is the first and only therapy to receive marketing authorization in the EU for the treatment of desmoid tumors
OGSIVEO is the first and only therapy to receive marketing authorization in the EU for the treatment of desmoid tumors
During this quarter, the company achieved a key milestone of reaching 1,000 DCGI approvals
The partnership aims to co-develop technologies set to revolutionize manufacturing of plasmid DNA (pDNA), a critical raw material for advanced medicines
7-OH is a concentrated byproduct of the kratom plant and has shown potential for abuse by binding to opioid receptors
This year, the OCTF focused on preparing a white paper on oral cancer elimination in India and updating its annual consensus guidelines
Investment will support AstraZeneca’s ambition to reach $80 billion revenue by 2030, with 50% generated in the US
Aims to support healthcare practitioners with evidence-based cough categorization tools that enable choosing the right molecules for effective & targeted relief from cough
This year, 40 women students are participating, selected through a rigorous process evaluating academic merit, research interest, and socio-economic background
Lupin and Zentiva sign license and supply agreement for commercializing Certolizumab
These medicines are essential in preventing RhD immunisation during pregnancy
Subscribe To Our Newsletter & Stay Updated
